Laurus Labs Q2 net profit surges on 33% rise in revenue
NDTV Profit
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Summary from The Hindu
Read the full story on The HinduFollow










